Literature DB >> 15861215

Variable sensitivity and specificity of TTF-1 antibodies in lung metastatic adenocarcinoma of colorectal origin.

Eva Compérat1, Fan Zhang, Cedric Perrotin, Thierry Molina, Pierre Magdeleinat, Beatrice Marmey, Jean-Francois Régnard, Josee Audouin, Saphie Camilleri-Broët.   

Abstract

Thyroid transcription factor-1 (TTF-1) is considered as a reliable marker for differential diagnosis in distinguishing primary adenocarcinomas of the lung from extrathoracic origins. We previously reported the first case of lung metastasis of colorectal origin, with nuclear expression of TTF-1. As most previous studies were performed on series of extrathoracic primary tumors, we raised the question of a possible role of lung microenviroment in TTF-1 expression. We investigated the rate of TTF-1 expression in lung metastases of extrathoracic adenocarcinomas and compared results of immunohistochemistry performed with different primary antibodies. Two different clones of antibodies (8G7G1/1 from Dako, SPT24 from Novocastra) raised against TTF-1 were used on 56 lung-metastatic malignant tumors, 41 from colorectal origin. A series of primary colorectal (90 cases) and primary pulmonary adenocarcinomas (86 cases) were also investigated. Four of 41 (10%) lung metastases of colorectal adenocarcinomas displayed a nuclear staining for TTF-1 with SPT24 clone. Three of the four positive cases displayed similar nuclear staining in primary and/or other extrathoracic metastatic sites as well as four of 90 (5%) primary colorectal adenocarcinomas, ruling out the role of lung microenvironment. None of them was positive with 8G7G1/1 clone. Sensitivity between two sets of antibodies was compared in 86 primary pulmonary adenocarcinomas. Nuclear staining was detected in 72 cases (84%) with Novocastra's antibody and 56 cases (65%) with Dako's. Significant discordance was observed (P < 0.01). These results suggest that the diagnostic virtue of TTF-1 detection depends on the used antibody's clone. The SPT24 clone seems to have a stronger affinity for TTF-1 protein but may lead to a few positive colorectal adenocarcinomas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15861215     DOI: 10.1038/modpathol.3800422

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  26 in total

1.  Reevaluation and reclassification of resected lung carcinomas originally diagnosed as squamous cell carcinoma using immunohistochemical analysis.

Authors:  Kyuichi Kadota; Jun-ichi Nitadori; Natasha Rekhtman; David R Jones; Prasad S Adusumilli; William D Travis
Journal:  Am J Surg Pathol       Date:  2015-09       Impact factor: 6.394

2.  Unexpected and potentially misleading TTF-1 expression: a word of caution.

Authors:  Abbas Agaimy; Peter H Wünsch
Journal:  Virchows Arch       Date:  2006-09-28       Impact factor: 4.064

3.  Thyroid transcription factor-1 may be expressed in ductal adenocarcinoma of the prostate:a potential pitfall.

Authors:  Tony Kiat-Hon Lim; Clarence Teo; Danilo M Giron; Yew-Lam Chong; Christopher Cheng; Puay-Hoon Tan
Journal:  J Clin Pathol       Date:  2007-08       Impact factor: 3.411

4.  TTF-1 staining in glioblastoma multiforme.

Authors:  Malcolm Galloway; Rosalind Sim
Journal:  Virchows Arch       Date:  2007-06-12       Impact factor: 4.064

5.  Identification of tissue of origin in carcinoma of unknown primary with a microarray-based gene expression test.

Authors:  Federico A Monzon; Fabiola Medeiros; Maureen Lyons-Weiler; W David Henner
Journal:  Diagn Pathol       Date:  2010-01-13       Impact factor: 2.644

6.  Positive immunostaining for thyroid transcription factor-1 in primary and metastatic colonic adenocarcinoma: a note of caution.

Authors:  D Penman; I Downie; F Roberts
Journal:  J Clin Pathol       Date:  2006-06       Impact factor: 3.411

Review 7.  Muscle metastasis of carcinoma.

Authors:  María José Molina-Garrido; Carmen Guillén-Ponce
Journal:  Clin Transl Oncol       Date:  2011-02       Impact factor: 3.405

8.  Warranting investigation of primary lung adenocarcinoma in patients with an extrapulmonary malignancy and lung nodules due to high frequency.

Authors:  Bing Zhu; Shavari Dalal; David W Kamp; Xiaoqi Lin
Journal:  Am J Clin Pathol       Date:  2014-03       Impact factor: 2.493

Review 9.  Metastatic non-small cell lung carcinoma a mimic of primary breast carcinoma-case series and literature review.

Authors:  Rola H Ali; Catalin Taraboanta; Tareq Mohammad; Malcolm M Hayes; Diana N Ionescu
Journal:  Virchows Arch       Date:  2017-11-05       Impact factor: 4.064

10.  Molecular pathological predictive diagnostics in a patient with non-small cell lung cancer treated with crizotinib therapy: A case report.

Authors:  Libor Stanek; Drahomira Springer; Bohuslav Konopasek; Michal Vocka; Petra Tesarova; Martin Syrucek; Lubos Petruzelka; Ales Vicha; Zdenek Musil
Journal:  Oncol Lett       Date:  2017-10-11       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.